GlassScriptPhysician profile
Luann Russo
NPI 1871614826
$4,138.19
in general payments reported to CMS, 2019-2025
23 companies · $1,161 in 2025
The $1,161 reported for 2025 was more than what 99% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $711 · 2022: $709 · 2023: $891 · 2024: $667 · 2025: $1,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,718.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $770.15 | 2021-2025 | Slynd, Nuvessa, Tyblume |
| Abbvie INC. | $713.90 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $625.87 | 2022-2025 | |
| Astellas Pharma US INC | $434.73 | 2021-2025 | Veozah |
| Exact Sciences Corporation | $331.00 | 2023-2025 | Cologuard Collection Kit |
| Cumberland Pharmaceuticals, INC. | $236.20 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $133.12 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $131.81 | 2021-2022 | |
| Millicent US INC | $92.24 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Organon LLC | $91.81 | 2022-2024 | |
| Agile Therapeutics, INC. | $85.22 | 2021-2022 | |
| Sage Therapeutics, LLC | $76.97 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $73.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $58.23 | 2023-2024 | Gardasil 9, Gardasil |
| Pfizer INC. | $54.02 | 2023-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $44.71 | 2021-2022 | |
| Coopersurgical, INC. | $42.24 | 2024 | Paragard T 380a |
| Organogenesis INC. | $38.78 | 2025 | Nushield |
| Bayer Healthcare Pharmaceuticals INC. | $34.02 | 2025 | |
| Urovant Sciences INC | $22.60 | 2022 | |
| Aspira Women'S Health INC | $17.57 | 2024 | Ova1 |
| Medicem INC. | $16.04 | 2021 | |
| Avion Pharmaceuticals | $13.75 | 2023 | Balcoltra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luann Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.